• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Alexion Pharmaceuticals Inc

+ Add to Watchlist

ALXN:US

162.8900 USD 4.1500 2.48%

As of 15:15:41 ET on 07/28/2014.

Company Profile for Alexion Pharmaceuticals Inc (ALXN)

Alexion Pharmaceuticals, Inc., a biopharmaceutical company, researches and develops proprietary immunoregulatory compounds for the treatment of autoimmune and cardiovascular diseases. The Company develops C5 complement inhibitors and Apogens which are two classes of potential therapeutic compounds designed to selectively target specific disease-causing segments of the immune system.

Contact Information

Alexion Pharmaceuticals Inc

352 Knotter Drive
Cheshire, CT 06410
United States
Phone: 1-203-272-2596
Fax: 1-203-271-8198

Key Executives for Alexion Pharmaceuticals Inc (ALXN)

Leonard BellCEO/Treasurer/Co-FounderVikas SinhaExec VP/CFO
David L HallalExec VP/Chief Commercial OfcrStephen P Squinto "Steve"Exec VP/Chief Global Ops Ofcr
Martin MackayExec VP/Head:Research & DevSaqib IslamSenior VP/Chief Strategy Ofcr
Elena RidloffExec Dir:Investor Relations

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil